TABARRINI, Oriana
 Distribuzione geografica
Continente #
AS - Asia 7.486
NA - Nord America 7.272
EU - Europa 5.210
SA - Sud America 754
Continente sconosciuto - Info sul continente non disponibili 559
AF - Africa 126
OC - Oceania 4
Totale 21.411
Nazione #
US - Stati Uniti d'America 7.097
CN - Cina 2.915
SG - Singapore 2.267
IT - Italia 986
VN - Vietnam 793
IE - Irlanda 769
UA - Ucraina 699
RU - Federazione Russa 668
HK - Hong Kong 654
SE - Svezia 595
BR - Brasile 582
DE - Germania 351
FI - Finlandia 246
FR - Francia 237
GB - Regno Unito 181
KR - Corea 179
IN - India 116
BE - Belgio 106
BD - Bangladesh 96
CA - Canada 89
TR - Turchia 88
PL - Polonia 84
AR - Argentina 60
MX - Messico 57
JP - Giappone 56
IQ - Iraq 52
AT - Austria 51
NL - Olanda 45
RO - Romania 45
PK - Pakistan 39
UZ - Uzbekistan 36
ES - Italia 35
SA - Arabia Saudita 34
ID - Indonesia 30
ZA - Sudafrica 29
CH - Svizzera 28
EC - Ecuador 25
CZ - Repubblica Ceca 23
CO - Colombia 20
PH - Filippine 20
VE - Venezuela 19
CI - Costa d'Avorio 17
CL - Cile 17
EG - Egitto 15
AE - Emirati Arabi Uniti 13
MA - Marocco 13
ET - Etiopia 12
KE - Kenya 12
PY - Paraguay 12
JO - Giordania 11
LB - Libano 10
MY - Malesia 10
LT - Lituania 9
GR - Grecia 8
IL - Israele 8
IR - Iran 8
LV - Lettonia 8
TN - Tunisia 8
PE - Perù 7
UY - Uruguay 7
PA - Panama 6
KG - Kirghizistan 5
NP - Nepal 5
AL - Albania 4
AO - Angola 4
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EU - Europa 4
JM - Giamaica 4
KZ - Kazakistan 4
PS - Palestinian Territory 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
AU - Australia 3
AZ - Azerbaigian 3
BH - Bahrain 3
HR - Croazia 3
LK - Sri Lanka 3
LY - Libia 3
NI - Nicaragua 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TM - Turkmenistan 2
TT - Trinidad e Tobago 2
Totale 20.833
Città #
Guangzhou 2.083
Singapore 1.665
Chandler 1.002
Dublin 769
San Jose 668
Hong Kong 636
Perugia 541
Dong Ket 503
Ashburn 416
San Mateo 414
Jacksonville 358
Santa Clara 289
Boardman 278
Beijing 215
Moscow 185
Medford 177
Princeton 176
Seoul 174
Lauterbourg 162
Ann Arbor 146
Los Angeles 145
Wilmington 134
Altamura 125
The Dalles 117
Lawrence 111
Ho Chi Minh City 110
New York 107
Brussels 106
Munich 104
Andover 95
Piscataway 78
Fremont 67
São Paulo 65
Hanoi 61
West Jordan 58
Warsaw 53
Tokyo 51
Des Moines 50
Orem 48
Dallas 47
Helsinki 47
Saint Petersburg 47
Turku 46
Redmond 43
Nanjing 40
Atlanta 35
Vienna 35
Montreal 34
Norwalk 34
Brooklyn 33
Buffalo 33
Council Bluffs 32
Woodbridge 31
Izmir 30
Chicago 29
Denver 29
Phoenix 29
Chennai 28
Bucharest 26
Baghdad 25
Hefei 25
Rome 25
Dhaka 24
Rio de Janeiro 23
Houston 21
Mexico City 21
San Paolo di Civitate 21
Shanghai 21
Dearborn 20
London 20
Poplar 20
Tashkent 20
Ankara 19
Falls Church 19
Redwood City 19
Stockholm 19
Columbus 18
Johannesburg 18
Abidjan 17
Da Nang 17
Toronto 17
Philadelphia 16
Spoleto 16
Milan 15
San Diego 15
Secaucus 15
Nuremberg 14
Porto Alegre 14
Seattle 14
Barnet 13
Charlotte 13
Chongqing 13
Lahore 13
Mumbai 13
Riyadh 13
Amsterdam 12
Belo Horizonte 12
Haiphong 12
Hanover 12
Manchester 12
Totale 13.956
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.142
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 343
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 337
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 320
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 319
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 251
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 206
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 186
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 163
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 156
A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity 156
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 155
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 154
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 149
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 146
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 145
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 144
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 142
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 142
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 141
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 139
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 139
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 136
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 136
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 136
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 136
2-phenylquinolones as HIV-1 Tat/TAR interaction inhibitors 135
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 135
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 133
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 130
6-Desfluoroquinolones as promising HIV transcription inhibitors 129
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 129
6-Aminoquinolones as New Potential Anti-HIV Agents 128
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 128
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 126
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 125
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 125
S. aureus NorA efflux pump: the discovery of new potent inhibitors 125
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 124
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 124
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 124
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 121
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 121
Acting on Tat-Mediated Transcription to Achieve a Long Term Control of HIV-1 Latency 120
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 118
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 117
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 116
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 116
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 115
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 115
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 115
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 114
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 114
Disegno di nuovi chinoloni ad attività antitubercolare: dalla 3D-QSAR agli algoritmi evolutivi. 113
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 113
A New Derivative with Ultra-Potent Anti-HIV Activity 111
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 111
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 111
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 110
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 109
A new 6-aminoquinolone compound with anti-HCMV activity 109
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 109
6-Hydroxy Derivative as New Desfluoroquinolone (DFQ): Synthesis and DNA-binding Study 109
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 109
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 108
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 108
Antiviral Activity of WC5, a new 6-aminoquinolone compound against Human Herpesviruses 107
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 106
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 106
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 106
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 105
Derivati 1,4-benzotiazinici come agenti anticonvulsivanti. 105
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 104
A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors. 103
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 103
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 103
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 103
QSAR study and VolSurf characterization of anti-HIV quinolone library 102
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 102
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 102
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 101
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 101
Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs 101
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 98
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 98
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 98
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 97
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 97
Antiviral 6-aminoquinolones: Molecolar basis for potency and selectivity. 96
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 96
In Vitro Activities of New Quinolones Against Helicobacter pylori 95
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 95
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 92
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 92
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 92
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 92
New compounds targeting the rna polymerase of influenza a and b viruses. 91
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15 90
Nuovi Tiopiranopiridinil Chinoloni 90
Symbiotic approach to drug design: N-[(4-chloro-3-sulfamoylbenzamido)-ethyl]propanolamine derivatives as β-adrenergic blocking agents with diuretic activity 90
Totale 14.830
Categoria #
all - tutte 85.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.681 0 301 36 112 116 11 32 488 89 51 211 234
2022/20232.873 199 482 37 268 266 304 3 171 1.001 21 87 34
2023/20243.324 69 191 67 30 20 29 2.333 28 137 88 148 184
2024/20253.157 35 270 115 261 367 163 292 182 544 196 483 249
2025/20266.430 426 446 322 834 835 596 1.054 366 708 520 235 88
2026/2027275 133 142 0 0 0 0 0 0 0 0 0 0
Totale 21.411